Vaccination Warnings and Invalid Reason Descriptions

If an immunization does not meet criteria during the immunization history evaluation process, vaccination warnings and invalid reasons identify why.

The warnings indicates that the immunization is acceptable in the series and does not need to be repeated, but was perhaps given as off-label (not meeting the vaccine licensure recommendation), or at an interval earlier than the recommended minimum interval.

Immunization warnings are based on guidance from the CDC National Immunization Program and may not be documented in the ACIP Guidelines.

An immunization flagged with an invalid vaccination reason did not meet the minimum criteria for satisfying the dose in the series schedule and must be repeated.

The following table contains vaccination warning and invalid reason descriptions:

Warning Type	Description
INVALID	Live vaccines not administered on same date must be separated by 28 days.
INVALID	Minimum interval from previous dose not met.
INVALID	Vaccine not licensed in U.S.
INVALID	HPV Bivalent vaccine is not appropriate for male vaccination or cannot be validated due to missing gender.
INVALID	Tdap administered at < 7 years of age and as dose 1, 2, or 3 should be repeated.
INVALID	Minimum interval from Dose 1 not met.
INVALID	Minimum age for this dose was not met.
INVALID	Measles or Varicella containing vaccine administered < 14 days prior to antibody containing product.
INVALID	Measles or Varicella containing vaccine administered less than recommended interval following antibody containing product.
INVALID	Antigen not found for this schedule.
INVALID	Vaccine marked as Compromised.
INVALID	Antigen recommended for booster dose only.
INVALID	Antigen not recommended for primary series.
INVALID	Patient age outside of recommended schedule.
WARNING	Seasonal Influenza Nasal and Novel Influ-H1N1-09 Nasal should not be administered at same visit but CDC does not recommend repeating the doses.
WARNING	Influenza 9+ years administered to patient under 9 years of age.
WARNING	Tdap administered at < 7 years of age and dose number > 3 but CDC does not recommend repeating the dose.
WARNING	PCV13 is recommended for children ages 14-59 mos. previously complete for PCV7.
WARNING	Rotavirus Dose 1 administered at age greater than recommended age. CDC recommends completing series.
WARNING	The minimum recommended interval between Td and Tdap is 5 years. However, shorter intervals may be counted as valid.
WARNING	DTaP-Hib-IPV Dose 4 administered at < 4 years of age does not satisfy the IPV dose 4 minimum age. Another IPV should be administered at >= 4 years of age.
WARNING	Patient may be on Twinrix alternative schedule.
WARNING	Minimum interval from previous dose not met but CDC does not recommend repeating this dose.
WARNING	The minimum recommended interval between DTaP-3 and DTaP-4 is 6 months. However, DTaP-4 need not be repeated if administered at least 4 months after DTaP-3.
WARNING	Antigen administered off-label but CDC does not recommend repeating dose.
WARNING	Influenza, 6-35 months administered at < 6months of age or > 35 months of age.
WARNING	Influenza, 36+ months administered at < 36 months of age.
WARNING	Tdap administered at > 64 years of age.
WARNING	Tdap administered at < 10 years of age.
WARNING	DTaP administered at >= 7 years of age.
WARNING	PPV23 administered at < 24 months of age.
WARNING	Td administered at < 7 years of age.
WARNING	DTaP/IPV is not approved for doses 1 through 3 of IPV but CDC does not recommend repeating the dose.
WARNING	DTaP/IPV is not approved for doses 1 through 4 of DTaP but CDC does not recommend repeating the dose.
WARNING	DTaP/HepB/IPV is not approved for doses 4 or 5 of DTaP or IPV but CDC does not recommend repeating the dose.
WARNING	Herpes Zoster administered to person < 50 years of age but CDC does not recommend repeating the dose.
WARNING	Pediatric/Adolescent vaccine recorded as administered to adult >=19 years of age.
WARNING	MMR/Varicella administered at >=13 years of age.
WARNING	TIV (Flu) High-Dose administered at < 65 years of age.
WARNING	DTaP/Hib/IPV should not be administered as dose 5 DTaP or to children >=5 years of age but CDC does not recommend repeating the dose.
WARNING	Influenza, 18+ years administered at < 18 years of age.
WARNING	Influenza, 48+ months administered at < 48 months of age.
WARNING	Multiple doses administered for single dose series. Revaccination for meningococcal recommended for high risk only.
WARNING	Multiple doses administered for single dose series.
WARNING	Multiple doses administered for single dose series. One dose of Tdap is recommended.
WARNING	Antigen not recommended for primary Hib series and CDC recommends disregarding in forecast.
WARNING	This additional dose not required.